Published in J Infect Dis on April 01, 1981
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol (1995) 3.63
Clonal diversity and host distribution in Bordetella bronchiseptica. J Bacteriol (1987) 2.59
Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect Immun (1982) 1.92
Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica. Infect Immun (1985) 1.75
Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect Immun (1985) 1.66
Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun (1985) 1.64
Outer membrane protein profiles of Haemophilus pleuropneumoniae. Infect Immun (1986) 1.46
Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun (1984) 1.36
Influence of potential virulence determinants on Bordetella bronchiseptica-induced ciliostasis. Infect Immun (1985) 1.31
Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J Bacteriol (1994) 1.28
Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26
Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes. J Bacteriol (1986) 1.25
Structure and biological properties of solubilized envelope proteins of Bordetella pertussis. Infect Immun (1983) 1.24
Heat-modifiable envelope proteins of Bordetella pertussis. Infect Immun (1986) 1.10
Vag8, a Bordetella pertussis bvg-regulated protein. Infect Immun (1998) 1.06
Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation. Infect Immun (1986) 1.02
Antibiotic resistance of degraded strains of Bordetella pertussis. Antimicrob Agents Chemother (1984) 0.96
Identification of two bvg-repressed surface proteins of Bordetella pertussis. Infect Immun (1995) 0.95
Isolation and characterization of Bordetella avium phase variants. Infect Immun (1991) 0.90
Identification and characterization of PtlC, an essential component of the pertussis toxin secretion system. Infect Immun (1999) 0.90
Cloning of Bordetella pertussis outer membrane proteins in Escherichia coli. J Bacteriol (1984) 0.88
Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion. Infect Immun (2002) 0.87
Requirements for assembly of PtlH with the pertussis toxin transporter apparatus of Bordetella pertussis. Infect Immun (2007) 0.87
Characterization of the outer membrane proteins of Bordetella avium. Infect Immun (1992) 0.84
Decrease in antimicrobial susceptibility of Bordetella bronchiseptica caused by antigenic modulation and phase variation. Antimicrob Agents Chemother (1988) 0.78
Novel phase-shift marker in cell surface proteins of Bordetella bronchiseptica. J Clin Microbiol (1989) 0.78
Crystal violet staining of Bordetella bronchiseptica colonies for differentiation of phase-I strains from variant strains in degraded phases. Can J Vet Res (1997) 0.75
Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol (1975) 16.73
Pittsburgh pneumonia agent: direct isolation from human lung tissue. J Infect Dis (1980) 11.36
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Natural populations of the genus Staphylococcus. Annu Rev Microbiol (1980) 5.63
Identification of Staphylococcus species with the API STAPH-IDENT system. J Clin Microbiol (1982) 5.17
A simple test system for the separation of staphylococci from micrococci. J Clin Microbiol (1975) 4.96
Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis (1993) 4.74
Use of shake cultures in a semisolid thioglycolate medium for differentiating staphylococci from micrococci. Appl Microbiol (1972) 4.25
Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol (1975) 3.92
Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57
Gluconate metabolism in Escherichia coli. J Bacteriol (1967) 3.53
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect Immun (1984) 2.70
Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun (1986) 2.63
Altered end-product patterns and catabolite repression in Escherichia coli. J Bacteriol (1966) 2.60
Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55
ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39
Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol Rev (1990) 2.37
Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31
Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest (1995) 2.28
Regulation of staphylococcal enterotoxin B. J Bacteriol (1969) 2.27
Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother (1989) 2.26
Identification of coagulase-positive Staphylococcus intermedius and Staphylococcus hyicus subsp. hyicus isolates from veterinary clinical specimens. J Clin Microbiol (1981) 2.25
Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18
Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother (1988) 2.13
The role of cyclic AMP in chemotaxis in Escherichia coli. Biochem Biophys Res Commun (1971) 1.99
Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: potential human-to-animal transmission. J Clin Microbiol (1999) 1.96
Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96
Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93
Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92
Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88
Identification of Staphylococcus species and subspecies by the chaperonin 60 gene identification method and reverse checkerboard hybridization. J Clin Microbiol (1997) 1.86
Species distribution of coagulase-negative staphylococcal isolates at a community hospital and implications for selection of staphylococcal identification procedures. J Clin Microbiol (1993) 1.85
Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71
Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67
Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Catabolite repression and pyruvate metabolism in Escherichia coli. J Bacteriol (1967) 1.66
Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Evaluation of the Vitek Systems Gram-Positive Identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol (1993) 1.53
Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52
Isolation of Staphylococcus hyicus subsp hyicus from a pig with septic polyarthritis. Am J Vet Res (1980) 1.52
Identification of the Staphylococcus sciuri species group with EcoRI fragments containing rRNA sequences and description of Staphylococcus vitulus sp. nov. Int J Syst Bacteriol (1994) 1.50
Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49
Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47
Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother (1998) 1.44
Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay. J Infect Dis (1989) 1.43
Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function. Hybridoma (1989) 1.43
The tryptophan gene cluster of Staphylococcus aureus. J Gen Microbiol (1970) 1.40
Effect of amino sugars on catabolite repression in Escherichia coli. J Bacteriol (1968) 1.37
A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37
Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36
Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36
Conjugal plasmid transfer (pAM beta 1) in Lactobacillus plantarum. Appl Environ Microbiol (1986) 1.33
Purification and Characterization of Glycerol Dehydratase from Lactobacillus reuteri. Appl Environ Microbiol (1990) 1.32
Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32
Utilization of Glycerol as a Hydrogen Acceptor by Lactobacillus reuteri: Purification of 1,3-Propanediol:NAD Oxidoreductase. Appl Environ Microbiol (1990) 1.31
The effect of cyclic 3',5'-AMP on catabolite repression of beta-galactosidase synthesis in Escherichia coli. Biochem Biophys Res Commun (1968) 1.30
Staphylococcus capitis subsp. ureolyticus subsp. nov. from human skin. Int J Syst Bacteriol (1991) 1.29
Isolation and characterization of cAMP suppressor mutants of Escherichia coli K12. Mol Gen Genet (1981) 1.28
Recommended minimal standards for description of new staphylococcal species. Subcommittee on the taxonomy of staphylococci and streptococci of the International Committee on Systematic Bacteriology. Int J Syst Bacteriol (1999) 1.28
Amino sugar sensitivity in Escherichia coli mutants unable to grow on N-acetylglucosamine. J Bacteriol (1970) 1.28
Transformation in Micrococcus lysodeikticus. J Gen Microbiol (1969) 1.26
Factors affecting transformation of Micrococcus lysodeikticus. J Bacteriol (1969) 1.26
Differentiation of Bacillus anthracis and other Bacillus species by lectins. J Clin Microbiol (1984) 1.25
Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25
N-acetylglucosamine assimilation in Escherichia coli and its relation to catabolite repression. J Bacteriol (1968) 1.24
Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24
Production and validation of the use of gamma phage for identification of Bacillus anthracis. J Clin Microbiol (2005) 1.21
Mechanism of CRP-mediated cya suppression in Escherichia coli. J Bacteriol (1983) 1.21
Altered hexose transport and salt sensitivity in cyclic adenosine 3',5'-monophosphate-deficient Escherichia coli. J Bacteriol (1975) 1.20
Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am J Trop Med Hyg (1988) 1.19
Comparison of the SmaI-digested chromosomes of Staphylococcus epidermidis and the closely related species Staphylococcus capitis and Staphylococcus caprae. Int J Syst Bacteriol (1994) 1.18
Isolation of plasmids in Legionella pneumophila and Legionella-like organisms. Infect Immun (1981) 1.17
Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17
Plasmid composition of Staphylococcus species. Can J Microbiol (1981) 1.17
Stimulation of cytochrome synthesis in Escherichia coli by cyclic AMP. Arch Biochem Biophys (1974) 1.14
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12
Anthrax in a dog. Vet Pathol (1994) 1.12
Glucosamine substitution and muramidase susceptibility in Bacillus anthracis. Can J Microbiol (1984) 1.12
Neutral lipids in the study of relationships of members of the family micrococcaceae. J Bacteriol (1971) 1.12
Aliphatic hydrocarbon contents of various members of the family Micrococcaceae. Lipids (1970) 1.11
Biphasic effect of pertussis vaccine on serum insulin in mice. Infect Immun (1983) 1.11
Chromatographic separation of puberty accelerating pheromone from male mouse urine. Biol Reprod (1976) 1.10
Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry (1986) 1.10
Purification and characterization of serotype 6 fimbriae from Bordetella pertussis and comparison of their properties with serotype 2 fimbriae. Infect Immun (1987) 1.10
Phase-shift markers in the genus Bordetella: loss of cytochrome d-629 in phase IV variants. Microbios (1981) 1.10